STOCK TITAN

Major EMAT holder NYX Trust and Knaggs disclose 10.03% merger stake

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D

Rhea-AI Filing Summary

Evolution Metals & Technologies Corp. reports that The NYX 2025 Irrevocable Trust and president Andrew F. Knaggs beneficially own 59,526,224 shares of common stock, representing 10.03% of the 593,349,852 shares outstanding after a recent business combination.

The trust received these shares as merger consideration in the business combination described in a recent Form 8-K. Knaggs, as individual trustee, has sole voting and dispositive power over the trust’s shares, making him a key 10% holder and company insider.

The reporting persons state they may buy more, hold, or sell shares over time and may discuss potential extraordinary corporate transactions, but they currently disclose no specific plans. Their shares are subject to a lock-up lasting until the third anniversary of the business combination closing, and they hold registration rights for future resale.

Positive

  • None.

Negative

  • None.

Insights

10.03% insider stake from merger, locked up but with future flexibility.

The filing shows The NYX 2025 Irrevocable Trust and Andrew F. Knaggs, the company’s president, owning 59,526,224 common shares, or 10.03% of Evolution Metals & Technologies Corp. This stake came entirely as merger consideration in a recent business combination.

Knaggs, as individual trustee, holds sole voting and dispositive power over the trust’s shares, concentrating influence in one insider. The narrative lists a wide range of potential future actions, from additional share purchases or sales to possible extraordinary corporate transactions, but without specific commitments.

A three-year lock-up from the business combination closing restricts near-term sales, while a registration rights agreement obligates the company to register the resale of these shares. Over time, how and when these locked-up shares are registered and potentially sold, as permitted under the agreements, may shape trading dynamics and governance discussions.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
As to Item 4 immediately above, the shares of common stock held by the Reporting Person were issued as merger consideration (the "Merger Consideration Shares") as a result of the consummation of that certain business combination ("Business Combination") as disclosed in the Issuer's Current Report on Form 8-K (Amendment No. 1) filed with the SEC on January 9, 2026. As to Items 7, 9, and 11 immediately above, the shares beneficially owned represent 59,526,224 shares of the Issuer's common stock directly beneficially owned by The NYX 2025 Irrevocable Trust UA, dated April 8, 2025. Andrew F. Knaggs may be deemed the beneficial owner of the shares held by The NYX 2025 Irrevocable Trust UA, dated April 8, 2025, as Andrew F. Knaggs, is the individual trustee, and Andrew F. Knaggs, has sole voting and dispositive power over the shares. As to Item 13 immediately above, the percentage is based on 593,349,852 common stock shares issued and outstanding as disclosed in the Issuer's Current Report on Form 8-K (Amendment No. 1) filed with the SEC on January 9, 2026. As to Item 14, immediately above, the type of reporting person is an irrevocable trust organized under the laws of Delaware.


SCHEDULE 13D




Comment for Type of Reporting Person:
As to Item 4 immediately above, the shares of common stock held by the Reporting Person were issued as merger consideration (the "Merger Consideration Shares") as a result of the consummation of that certain business combination ("Business Combination") as disclosed in the Issuer's Current Report on Form 8-K (Amendment No. 1) filed with the SEC on January 9, 2026. As to Items 7, 9, and 11 immediately above, the shares beneficially owned represent 59,526,224 shares of the Issuer's common stock directly beneficially owned by The NYX 2025 Irrevocable Trust UA, dated April 8, 2025. Andrew F. Knaggs may be deemed the beneficial owner of the shares held by The NYX 2025 Irrevocable Trust UA, dated April 8, 2025, as Andrew F. Knaggs, is the individual trustee, and Andrew F. Knaggs, has sole voting and dispositive power over the shares. As to Item 13 immediately above, the percentage is based on 593,349,852 common stock shares issued and outstanding as disclosed in the Issuer's Current Report on Form 8-K (Amendment No. 1) filed with the SEC on January 9, 2026.


SCHEDULE 13D


The NYX 2025 Irrevocable Trust UA, dated April 8, 2025
Signature:/s/ Andrew F. Knaggs
Name/Title:The NYX 2025 Irrevocable Trust UA, dated April 8, 2025, Individual Trustee
Date:02/13/2026
Andrew F. Knaggs
Signature:/s/ Andrew F. Knaggs
Name/Title:Andrew F. Knaggs
Date:02/13/2026

FAQ

How many Evolution Metals & Technologies (EMAT) shares do the reporting persons own?

The NYX 2025 Irrevocable Trust and Andrew F. Knaggs beneficially own 59,526,224 EMAT common shares. This represents 10.03% of the 593,349,852 shares of common stock issued and outstanding immediately following the business combination described in the company’s Form 8-K (Amendment No. 1).

What percentage of Evolution Metals & Technologies (EMAT) does Andrew F. Knaggs control?

Andrew F. Knaggs is deemed to beneficially own 10.03% of EMAT common stock. He serves as president of the issuer and sole trustee of The NYX 2025 Irrevocable Trust, holding sole voting and dispositive power over 59,526,224 shares owned by the trust.

How did The NYX 2025 Irrevocable Trust acquire its EMAT shares?

The trust received all 59,526,224 EMAT shares as merger consideration. It exchanged its shares in the target company for Evolution Metals & Technologies common stock upon consummation of a business combination, as described in the issuer’s Current Report on Form 8-K (Amendment No. 1).

Are the EMAT shares held by The NYX 2025 Irrevocable Trust subject to a lock-up?

Yes, the reporting persons’ EMAT shares are subject to a multi-year lock-up. Under a Company Equityholder Support and Lock-Up Agreement, they agreed not to sell or hedge their common stock until the period ending on the third anniversary of the business combination closing, subject to the agreement’s terms.

What future actions do the EMAT reporting persons say they might take with their shares?

The reporting persons may buy more, hold, or sell EMAT shares over time. They also state they may discuss potential extraordinary corporate transactions, such as mergers or changes to capital structure, but they affirm they have not formulated specific plans beyond what is described.

What registration rights do the EMAT reporting persons hold?

The reporting persons entered into a Registration Rights Agreement at the business combination closing. Under this agreement, Evolution Metals & Technologies is obligated to file a registration statement to register the resale of common stock held by the reporting persons, facilitating potential future liquidity events for their stake.
Evolution Metals

NASDAQ:EMAT

EMAT Rankings

EMAT Latest News

EMAT Latest SEC Filings

EMAT Stock Data

6.03B
408.64M
Miscellaneous Electrical Machinery, Equipment & Supplies
WEST PALM BEACH